|

Skin Reactions Related to Thoracic Implantable Chamber Dressings

RECRUITINGSponsored by Institut Curie
Actively Recruiting
SponsorInstitut Curie
Started2025-06-10
Est. completion2026-12-10
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07158879

Summary

Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients over 18 years of age
* New chemotherapy patients (1st line of treatment only)
* Thoracic PAC

Exclusion Criteria:

* PICC Line and femoral PAC;
* Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
* Disunion requiring treatment
* Patients treated for hematological cancer;
* Persons deprived of their liberty or under guardianship (including curatorship);
* Adults under court protection;
* Inability to participate in the study for geographical, social or psychological reasons.
* No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.).
* Opposition to data use

Conditions2

CancerSkin Diseases

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.